ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 183 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 6.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $56,000 | -24.3% | 7,287 | +30.4% | 0.00% | -33.3% |
Q1 2019 | $74,000 | -14.9% | 5,587 | 0.0% | 0.00% | -25.0% |
Q4 2018 | $87,000 | -20.9% | 5,587 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $110,000 | -31.2% | 5,587 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $160,000 | +21.2% | 5,587 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $132,000 | +10.0% | 5,587 | 0.0% | 0.01% | +20.0% |
Q4 2017 | $120,000 | +37.9% | 5,587 | +51.5% | 0.01% | +25.0% |
Q3 2017 | $87,000 | +52.6% | 3,687 | +27.1% | 0.00% | +33.3% |
Q2 2017 | $57,000 | +83.9% | 2,900 | +93.3% | 0.00% | +50.0% |
Q1 2017 | $31,000 | +10.7% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $28,000 | -9.7% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $31,000 | -46.6% | 1,500 | -43.2% | 0.00% | +100.0% |
Q2 2016 | $58,000 | -69.0% | 2,640 | -62.6% | 0.00% | -66.7% |
Q1 2016 | $187,000 | -53.5% | 7,050 | -25.0% | 0.00% | -50.0% |
Q4 2015 | $402,000 | +323.2% | 9,400 | +161.1% | 0.01% | +500.0% |
Q3 2015 | $95,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |